title: Imaging radiation-induced normal tissue injury.
abstract: Technological developments in radiation therapy and other cancer therapies have led to a progressive increase in five-year survival rates over the last few decades. Although acute effects have been largely minimized by both technical advances and medical interventions, late effects remain a concern. Indeed, the need to identify those individuals who will develop radiation-induced late effects, and to develop interventions to prevent or ameliorate these late effects is a critical area of radiobiology research. In the last two decades, preclinical studies have clearly established that late radiation injury can be prevented/ameliorated by pharmacological therapies aimed at modulating the cascade of events leading to the clinical expression of radiation-induced late effects. These insights have been accompanied by significant technological advances in imaging that are moving radiation oncology and normal tissue radiobiology from disciplines driven by anatomy and macrostructure to ones in which important quantitative functional, microstructural, and metabolic data can be noninvasively and serially determined. In the current article, we review use of positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance (MR) imaging and MR spectroscopy to generate pathophysiological and functional data in the central nervous system, lung, and heart that offer the promise of, (1) identifying individuals who are at risk of developing radiation-induced late effects, and (2) monitoring the efficacy of interventions to prevent/ameliorate them.
authors.affiliation: Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. mrobbins@wfubmc.edu
authors.forename: Mike E
authors.initials: ME
authors.lastname: Robbins
authors.forename: Judy K
authors.initials: JK
authors.lastname: Brunso-Bechtold
authors.forename: Ann M
authors.initials: AM
authors.lastname: Peiffer
authors.forename: Christina I
authors.initials: CI
authors.lastname: Tsien
authors.forename: Janet E
authors.initials: JE
authors.lastname: Bailey
authors.forename: Lawrence B
authors.initials: LB
authors.lastname: Marks
mesh_terms: D000818:Animals; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology; D016371:Cranial Irradiation / Q000009:adverse effects; D003952:Diagnostic Imaging / Q000379:methods*; D056324:Diffusion Tensor Imaging / Q000379:methods; D006335:Heart Injuries / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D059906:Neuroimaging / Q000379:methods; D055420:Perfusion Imaging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods; D057285:Precision Medicine; D011832:Radiation Injuries / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D011833:Radiation Injuries, Experimental / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000473:pathology; D017564:Radiation Pneumonitis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology; D011836:Radiation Tolerance; D011859:Radiography; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014652:Vascular Diseases / Q000209:etiology / Q000473:pathology